RootsAnalysis is pleased to announce the publication of its recent study, titled, “Oligonucleotide Synthesis, Modificationand Purification Services Market:Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030.”
Thereport features an extensive study of the current scenario and future potentialof the custom synthesis, modification and purification services market foroligonucleotides, which are intended for research, diagnostic, and therapeuticapplications. The study includes in-depth analyses, highlighting thecapabilities of service providers engaged in this domain. In addition to otherelements, it includes:
· A detailed review of the current status ofthe market with respect to oligonucleotide manufacturers focused on researchand diagnostic, and therapeutic applications.
· A competitiveness analysis of prominentoligonucleotide manufacturers, featuring insightful pictorial summaries andrepresentations.
· Elaborate profiles of key players that offera diverse range of capabilities for custom synthesis, modification andpurification of oligonucleotides.
· An analysis of the various partnershipspertaining to oligonucleotide manufacturing, which have been established in therecent past.
· An analysis of the various expansioninitiatives undertaken by service providers engaged in this domain.
· A detailed analysis of completed, ongoing andplanned clinical research studies of various oligonucleotide-based drugproducts.
· An estimate of the overall, annual capacityfor manufacturing oligonucleotides based on data reported by industrystakeholders in the public domain.
· An informed estimate of the annual clinicaland commercial demand for oligonucleotides.
· A discussion on affiliated trends, keydrivers and challenges, under an elaborate SWOT framework.
· A survey analysis featuring inputs solicitedfrom various experts who are directly / indirectly involved in providing customsynthesis, modification and purification services for oligonucleotides.
Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)
Typeof Manufacturing
· Custom Manufacturing
· Large-scale Manufacturing
Typeof Oligonucleotides Manufactured
· Antisense Oligonucleotides
· miRNAs
· shRNAs
· siRNAs
· Other Oligonucleotides
Scaleof Operation
· Clinical
· Commercial
Purposeof Production
· In-house
· Outsourced
TargetTherapeutic Area
· Autoimmune Disorders
· Cardiovascular Disorders
· Genetic Disorders
· Infectious Diseases
· Metabolic Disorders
· Neuromuscular Disorders
· Oncological Disorders
· Ophthalmic Disorders
· Other Therapeutic Areas
Sizeof manufacturer
· Small
· Mid-sized
· Large
KeyGeographical Region
· North America
· Europe
· Asia-Pacific and Rest of the World
Transcriptsof interviews held with the following senior level representatives of stakeholdercompanies
· Joachim Bertram (Chief Scientific Officer andManaging Director, IBA Lifesciences)
· Tobias Pohlmann (Founder and ManagingDirector, BianoScience)
Keycompanies covered in the report
· Agilent Technologies
· Ajinomoto Bio-Pharma Services
· BioSpring
· CordenPharma
· Integrated DNA Technologies
· Kaneka Eurogentec
· LGC Biosearch Technologies
· Microsynth
· Nitto Denko Avecia
· Sigma Aldrich
· Thermo Fisher Scientific
· Trilink Biotechnologies
Formore information, please click on the following link:
https://www.rootsanalysis.com/reports/304/request-sample.html
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
